REFILE-UPDATE 2-FDA knocks back Achaogen's drug for bloodstream infection

June 26 (Reuters) - The U.S. Food and Drug Administration cleared Achaogen Inc's antibiotic to treat adults with complicated urinary tract infections, but shares slumped 25 percent as the drug failed to win approval for treating bloodstream infections.